Home Contact Center Add this

Let's meet

ICI Immune Checkpoint Inhibitors

ICI Immune Checkpoint Inhibitors
March 15-17, 2016ALL EVENTS

13 January 2016 / international

Debiopharm International SA and EORTC announce a collaboration to investigate Triptorelin for treatment of Salivary Gland Cancers [Read more]

11 January 2016 / international

Debiopharm International SA and Arbor Pharmaceuticals, LLC announce their US commercialization partnership for Triptorelin in Central Precocious Puberty [Read more]

13 December 2015 / international

Challenge Debiopharm Inartis: appel à projets [Read more]

ALL NEWS

08 September 2015

Debiopharm International SA and Solid Biosciences, LLC, announce a collaboration to explore the use of Alisporivir (Debio 025) in muscular dystrophy. [Read more]

16 April 2015

Debiopharm International SA announces results of 2 key oncology programs at 2015 AACR Conference [Read more]

18 November 2014

Debiopharm Group™ presents advances of two key oncology clinical programs at the 26th EORTC-NCI-AACR symposium in Barcelona [Read more]

ALL NEWS

18 December 2014

Debiopharm Investment, Ardian, Nixdorf Foundation and Bernis today acquire Eco Delta solar activities [Read more]

27 November 2014

Debiopharm Investment becomes a minority shareholder in Haut-Lac International Bilingual School in St-Légier (VD) [Read more]

17 November 2014

Coorpacademy, établi à l’EPFL et l’un des leaders des MOOCs à destination des entreprises, lève 3,2 millions d’euros auprès de Debiopharm Investment et du fonds français NextStage [Read more]

ALL NEWS

08 November 2015

Clinical Safety, Pharmacokinetics and Early Evidence of Activity of The Oral IAPs Inhibitor Debio 1143 in Combination with Carboplatin and Paclitaxel: a Phase1 Study [Read more]

23 October 2015

SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells [Read more]

21 September 2015

The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma. [Read more]

ALL NEWS

bulle slideshow group

bulle slideshow diagnostics

bulle slideshow international

bulle slideshow investment

bulle slideshow research